Progression in translational research on spinal cord injury based on microenvironment imbalance

Stover, S. L., DeVivo, M. J. & Go, B. K. History, implementation, and current status of the National Spinal Cord Injury Database. Arch. Phys. Med. Rehabil. 80, 1365–1371 (1999).

Parent, S., Barchi, S., LeBreton, M., Casha, S. & Fehlings, M. G. The impact of specialized centers of care for spinal cord injury on length of stay, complications, and mortality: a systematic review of the literature. J. Neurotrauma 28, 1363–1370 (2011).

Injury, G. B. D. T. B. & Spinal Cord Injury, C. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 56–87 (2019).

Organization, W. H. International perspectives on spinal cord injury. Weed Res. 11, 314–316 (2013).

Kang, Y. et al. Epidemiology of worldwide spinal cord injury: a literature review. J. Neurorestoratol. 6, 1–9 (2017).

Li, H. L. et al. Epidemiology of traumatic spinal cord injury in Tianjin, China: An 18-year retrospective study of 735 cases. J. Spinal Cord Med. 42, 778–785 (2019).

Chan, B. C., Cadarette, S. M., Wodchis, W. P., Krahn, M. D. & Mittmann, N. The lifetime cost of spinal cord injury in Ontario, Canada: A population-based study from the perspective of the public health care payer. J. Spinal Cord Med. 42, 184–193 (2019).

Stillman, M. D., Barber, J., Burns, S., Williams, S. & Hoffman, J. M. Complications of Spinal Cord Injury Over the First Year After Discharge From Inpatient Rehabilitation. Arch. Phys. Med. Rehabil. 98, 1800–1805 (2017).

LaPlaca, M. C., Simon, C. M., Prado, G. R. & Cullen, D. K. CNS injury biomechanics and experimental models. Prog. Brain Res. 161, 13–26 (2007).

Choo, A. M. et al. Contusion, dislocation, and distraction: primary hemorrhage and membrane permeability in distinct mechanisms of spinal cord injury. J. Neurosurg. Spine 6, 255–266 (2007).

Pineau, I. & Lacroix, S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 500, 267–285 (2007).

Palandi, J., Bobinski, F., de Oliveira, G. M. & Ilha, J. Neuropathic pain after spinal cord injury and physical exercise in animal models: a systematic review and meta-analysis. Neurosci. Biobehav Rev. 108, 781–795 (2020).

Stokes, B. T. Experimental spinal cord injury: a dynamic and verifiable injury device. J. Neurotrauma 9, 129–131 (1992).

Scheff, S. W., Rabchevsky, A. G., Fugaccia, I., Main, J. A. & Lumpp, J. E. Jr. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179–193 (2003).

Marcol, W. et al. Air gun impactor−a novel model of graded white matter spinal cord injury in rodents. J. Reconstr. Microsurg. 28, 561–568 (2012).

Alizadeh, A., Dyck, S. M. & Karimi-Abdolrezaee, S. Traumatic Spinal Cord Injury: an overview of pathophysiology, models and acute injury mechanisms. Front. Neurol. 10, 282 (2019).

Rivlin, A. S. & Tator, C. H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg. Neurol. 10, 38–43 (1978).

Borgens, R. B. & Shi, R. Immediate recovery from spinal cord injury through molecular repair of nerve membranes with polyethylene glycol. FASEB J. 14, 27–35 (2000).

Vanický, I., Urdzíková, L., Saganová, K., Cízková, D. & Gálik, J. A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat. J. Neurotrauma 18, 1399–1407 (2001).

Guha, A., Tator, C. H., Endrenyi, L. & Piper, I. Decompression of the spinal cord improves recovery after acute experimental spinal cord compression injury. Paraplegia 25, 324–339 (1987).

Etz, D. C. et al. Spinal cord ischemia in open and endovascular thoracoabdominal aortic aneurysm repair: new concepts. J. Cardiovasc Surg. 55, 159–168 (2014).

Wynn, M. M. & Acher, C. W. A modern theory of spinal cord ischemia/injury in thoracoabdominal aortic surgery and its implications for prevention of paralysis. J. Cardiothorac. Vasc. Anesth. 28, 1088–1099 (2014).

Tarlov, I. M. & Keener, E. B. Subarachnoid hemorrhage and tumor implants from spinal sarcoma in an infant. Neurology 3, 384–390 (1953).

Saadoun, S., Bell, B. A., Verkman, A. S. & Papadopoulos, M. C. Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice. Brain 131, 1087–1098 (2008).

Rosenzweig, E. S. & McDonald, J. W. Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Curr. Opin. Neurol. 17, 121–131 (2004).

Li, X. et al. Scaffold-facilitated locomotor improvement post complete spinal cord injury: Motor axon regeneration versus endogenous neuronal relay formation. Biomaterials 197, 20–31 (2019).

Li, J. & Lepski, G. Cell transplantation for spinal cord injury: a systematic review. Biomed. Res. Int. 2013, 786475 (2013).

Pastrana, E. et al. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J. Neurosci. 26, 5347–5359 (2006).

Brown, A. R. & Martinez, M. Thoracic spinal cord hemisection surgery and open-field locomotor assessment in the rat. J. Vis. Exp. https://doi.org/10.3791/59738 (2019).

Zörner, B. et al. Profiling locomotor recovery: comprehensive quantification of impairments after CNS damage in rodents. Nat. Methods 7, 701–708 (2010).

Tran, A. P., Warren, P. M. & Silver, J. The biology of regeneration failure and success after spinal cord injury. Physiol. Rev. 98, 881–917 (2018).

Li, Y. et al. Microglia-organized scar-free spinal cord repair in neonatal mice. Nature 587, 613–618 (2020).

Tator, C. H. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol. 5, 407–413 (1995).

Rowland, J. W., Hawryluk, G. W., Kwon, B. & Fehlings, M. G. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg. Focus 25, E2 (2008).

Hassannejad, Z. et al. The fate of neurons after traumatic spinal cord injury in rats: A systematic review. Iran. J. Basic Med. Sci. 21, 546–557 (2018).

Springer, J., Azbill, R. & Knapp, P. Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5, 943–946 (1999).

Choo, A., Liu, J., Dvorak, M., Tetzlaff, W. & Oxland, T. Secondary pathology following contusion, dislocation, and distraction spinal cord injuries. Exp. Neurol. 212, 490–506 (2008).

Liu, X. Z. et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395–5406 (1997).

Liu, M. et al. Necroptosis, a novel type of programmed cell death, contributes to early neural cells damage after spinal cord injury in adult mice. J. Spinal Cord. Med. 38, 745–753 (2015).

Levy, J. M. M., Towers, C. G. & Thorburn, A. Targeting autophagy in cancer. Nat. Rev. Cancer 17, 528–542 (2017).

Zhang, Q., Huang, C., Meng, B., Tang, T. S. & Yang, H. L. Changes in autophagy proteins in a rat model of spinal cord injury. Chin. J. Traumatol. 17, 193–197 (2014).

Hernandez, D. et al. Regulation of presynaptic neurotransmission by macroautophagy. Neuron 74, 277–284 (2012).

Tran, A. P., Warren, P. M. & Silver, J. Regulation of autophagy by inhibitory CSPG interactions with receptor PTPsigma and its impact on plasticity and regeneration after spinal cord injury. Exp. Neurol. 328, 113276 (2020).

Ko, S. H., Apple, E. C., Liu, Z. & Chen, L. Age-dependent autophagy induction after injury promotes axon regeneration by limiting NOTCH. Autophagy 16, 2052–2068 (2020).

Hwang, J. Y., Yan, J. & Zukin, R. S. Autophagy and synaptic plasticity: epigenetic regulation. Curr. Opin. Neurobiol. 59, 207–212 (2019).

Ray, S. K. Modulation of autophagy for neuroprotection and functional recovery in traumatic spinal cord injury. Neural Regen. Res. 15, 1601–1612 (2020).

Lipinski, M. M., Wu, J., Faden, A. I. & Sarkar, C. Function and mechanisms of autophagy in brain and spinal cord trauma. Antioxid. Redox Signal. 23, 565–577 (2015).

Bisicchia, E. et al. Autophagy inhibition favors survival of rubrospinal neurons after spinal cord hemisection. Mol. Neurobiol. 54, 4896–4907 (2017).

Lin, C. W., Chen, B., Huang, K. L., Dai, Y. S. & Teng, H. L. Inhibition of autophagy by estradiol promotes locomotor recovery after spinal cord injury in rats. Neurosci. Bull. 32, 137–144 (2016).

Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060–1072 (2012).

Yao, X. et al. Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis. Neural Regen. Res. 14, 532–541 (2019).

Zhang, Y. et al. Ferroptosis inhibitor SRS 16-86 attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury. Brain Res. 1706, 48–57 (2019).

Fink, S. L. & Cookson, B. T. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol. 8, 1812–1825 (2006).

Zheng, G. et al. Carbon monoxide releasing molecule-3 alleviates neuron death after spinal cord injury via inflammasome regulation. EBioMedicine 40, 643–654 (2019).

Hassannejad, Z. et al. Axonal degeneration and demyelination following traumatic spinal cord injury: a systematic review and meta-analysis. J. Chem. Neuroanat. 97, 9–22 (2019).

Liu, K. et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 1075–1081 (2010).

Park, K. K. et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322, 963–966 (2008).

Huang, H. et al. AKT-dependent and -independent pathways mediate PTEN deletion-induced CNS axon regeneration. Cell Death Dis. 10, 203 (2019).

Zhang, J., Yang, D., Huang, H., Sun, Y. & Hu, Y. Coordination of necessary and permissive signals by PTEN inhibition for CNS axon regeneration. Front. Neurosci. 12, 558 (2018).

Miao, L. et al. mTORC1 is necessary but mTORC2 and GSK3beta are inhibitory for AKT3-induced axon regeneration in the central nervous system. Elife 5, e14908 (2016).

Liu, G., Detloff, M. R., Miller, K. N., Santi, L. & Houle, J. D. Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injury. Exp. Neurol. 233, 447–456 (2012).

Yang, P., Wen, H., Ou, S., Cui, J. & Fan, D. IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Exp. Neurol. 236, 19–27 (2012).

Zareen, N. et al. Stimulation-dependent remodeling of the corticospinal tract requires reactivation of growth-promoting developmental signaling pathways. Exp. Neurol. 307, 133–144 (2018).

Blanquie, O. & Bradke, F. Cytoskeleton dynamics in axon regeneration. Curr. Opin. Neurobiol. 51, 60–69 (2018).

Tom, V. J., Steinmetz, M. P., Miller, J. H., Doller, C. M. & Silver, J. Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J. Neurosci. 24, 6531–6539 (2004).

Ertürk, A., Hellal, F., Enes, J. & Bradke, F. Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration. J. Neurosci. 27, 9169–9180 (2007).

Conde, C. & Cáceres, A. Microtubule assembly, organization and dynamics in axons and dendrites. Nat. Rev. Neurosci. 10, 319–332 (2009).

Jiang, H., Guo, W., Liang, X. & Rao, Y. Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 120, 123–135 (2005).

Zhou, F. Q., Zhou, J., Dedhar, S., Wu, Y. H. & Snider, W. D. NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42, 897–912 (2004).

Schaefer, A. W. et al. Coordination of actin filament and microtubule dynamics during neurite outgrowth. Dev. Cell 15, 146–162 (2008).

Zhang, X. F., Schaefer, A. W., Burnette, D. T., Schoonderwoert, V. T. & Forscher, P. Rho-dependent contractile responses in the neuronal growth cone are independent of classical peripheral retrograde actin flow. Neuron 40, 931–944 (2003).

He, Z. & Jin, Y. Intrinsic control of axon regeneration. Neuron 90, 437–451 (2016).

Han, Q. et al. Restoring cellular energetics promotes axonal regeneration and functional recovery after spinal cord injury. Cell Metab. 31, 623–641.e628 (2020).

McEwen, M. L., Sullivan, P. G., Rabchevsky, A. G. & Springer, J. E. Targeting mitochondrial function for the treatment of acute spinal cord injury. Neurotherapeutics 8, 168–179 (2011).

Jia, Z. Q. et al. Time representation of mitochondrial morphology and function after acute spinal cord injury. Neural Regen. Res. 11, 137–143 (2016).

Han, S. M., Baig, H. S. & Hammarlund, M. Mitochondria localize to injured axons to support regeneration. Neuron 92, 1308–1323 (2016).

Zhou, B. et al. Facilitation of axon regeneration by enhancing mitochondrial transport and rescuing energy deficits. J. Cell Biol. 214, 103–119 (2016).

Wang, C. et al. An injectable heparin-Laponite hydrogel bridge FGF4 for spinal cord injury by stabilizing microtubule and improving mitochondrial function. Theranostics 9, 7016–7032 (2019).

Wang, X. et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893–906 (2011).

Yang, W. & Hekimi, S. A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans. PLoS Biol. 8, e1000556 (2010).

Yee, C., Yang, W. & Hekimi, S. The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. elegans. Cell 157, 897–909 (2014).

Sheng, Z. H. The interplay of axonal energy homeostasis and mitochondrial trafficking and anchoring. Trends Cell Biol. 27, 403–416 (2017).

Chung, W. S. et al. Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504, 394–400 (2013).

Allen, N. J. et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486, 410–414 (2012).

Kucukdereli, H. et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc. Natl. Acad. Sci. USA 108, E440–E449 (2011).

Allen, N. J. & Barres, B. A. Neuroscience: Glia - more than just brain glue. Nature 457, 675–677 (2009).

Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481–487 (2017).

Bush, T. G. et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23, 297–308 (1999).

Wilhelmsson, U. et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. USA 103, 17513–17518 (2006).

Hara, M. et al. Interaction of reactive astrocytes with type Ⅰ collagen induces astrocytic scar formation through the integrin-N-cadherin pathway after spinal cord injury. Nat. Med. 23, 818–828 (2017).

Silver, J. & Miller, J. H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146–156 (2004).

Mikami, T. & Kitagawa, H. Biosynthesis and function of chondroitin sulfate. Biochim. Biophys. Acta 1830, 4719–4733 (2013).

Fawcett, J. W. The extracellular matrix in plasticity and regeneration after CNS injury and neurodegenerative disease. Prog. Brain Res. 218, 213–226 (2015).

Bradbury, E. J. et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636–640 (2002).

Wang, D., Ichiyama, R. M., Zhao, R., Andrews, M. R. & Fawcett, J. W. Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J. Neurosci. 31, 9332–9344 (2011).

Brambilla, R. et al. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202, 145–156 (2005).

Faulkner, J. R. et al. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24, 2143–2155 (2004).

Wanner, I. B. et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J. Neurosci. 33, 12870–12886 (2013).

Anderson, M. A. et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature 532, 195–200 (2016).

Nathan, F. M. & Li, S. Environmental cues determine the fate of astrocytes after spinal cord injury. Neural Regen. Res. 12, 1964–1970 (2017).

Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193–215 (2011).

Hall, C. N. et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55–60 (2014).

Bell, R. D. et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409–427 (2010).

Silver, J. The glial scar is more than just astrocytes. Exp. Neurol. 286, 147–149 (2016).

Dias, D. O. et al. Reducing pericyte-derived scarring promotes recovery after spinal cord injury. Cell 173, 153–165.e122 (2018).

Gurtner, G. C., Werner, S., Barrandon, Y. & Longaker, M. T. Wound repair and regeneration. Nature 453, 314–321 (2008).

Zhu, Y., Soderblom, C., Trojanowsky, M., Lee, D. H. & Lee, J. K. Fibronectin Matrix Assembly after Spinal Cord Injury. J. Neurotrauma 32, 1158–1167 (2015).

Goritz, C. et al. A pericyte origin of spinal cord scar tissue. Science 333, 238–242 (2011).

Hesp, Z. C. et al. Proliferating NG2-cell-dependent angiogenesis and scar formation alter axon growth and functional recovery after spinal cord injury in mice. J. Neurosci. 38, 1366–1382 (2018).

Sauer, R. S. et al. Blood-spinal cord barrier breakdown and pericyte deficiency in peripheral neuropathy. Ann. N. Y. Acad. Sci. 1405, 71–88 (2017).

Stark, K. et al. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and ‘instruct’ them with pattern-recognition and motility programs. Nat. Immunol. 14, 41–51 (2013).

Karow, M. et al. Reprogramming of pericyte-derived cells of the adult human brain into induced neuronal cells. Cell Stem Cell 11, 471–476 (2012).

De La Fuente, A. G. et al. Pericytes stimulate oligodendrocyte progenitor cell differentiation during CNS remyelination. Cell Rep. 20, 1755–1764 (2017).

Orr, M. B. & Gensel, J. C. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics 15, 541–553 (2018).

David, S. & Kroner, A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388–399 (2011).

Hines, D. J., Hines, R. M., Mulligan, S. J. & Macvicar, B. A. Microglia processes block the spread of damage in the brain and require functional chloride channels. Glia 57, 1610–1618 (2009).

Perrin, F. E., Lacroix, S., Aviles-Trigueros, M. & David, S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 128, 854–866 (2005).

Haynes, S. E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512–1519 (2006).

Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453–461 (2008).

Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14–20 (2014).

Ginhoux, F. & Prinz, M. Origin of microglia: current concepts and past controversies. Cold Spring Harb. Perspect. Biol. 7, a020537 (2015).

Greenhalgh, A. D. & David, S. Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J. Neurosci. 34, 6316–6322 (2014).

Beck, K. D. et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. Brain 133, 433–447 (2010).

Conti, A. et al. Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Res. Rev. 54, 205–218 (2007).

Bains, M. & Hall, E. D. Antioxidant therapies in traumatic brain and spinal cord injury. Biochim. Biophys. Acta 1822, 675–684 (2012).

Lawrence, T. & Natoli, G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750–761 (2011).

Yang, L. et al. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine (Philos. Pa 1976) 29, 966–971 (2004).

Ferguson, A. R. et al. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J. Neurosci. 28, 11391–11400 (2008).

Takahashi, K., Rochford, C. D. & Neumann, H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201, 647–657 (2005).

Shechter, R. et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6, e1000113 (2009).

Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N. & Crowe, M. S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73–76 (1997).

Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N. & Beattie, M. S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73–76 (1997).

Li, G. L., Farooque, M., Holtz, A. & Olsson, Y. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol. 98, 473–480 (1999).

Fan, H. et al. Involvement of endoplasmic reticulum stress in the necroptosis of microglia/macrophages after spinal cord injury. Neuroscience 311, 362–373 (2015).

Fan, H. et al. Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages/microglia polarization to M1 phenotype after spinal cord injury in rats. J. Neuroinflammation 16, 206 (2019).

Garcia, E., Aguilar-Cevallos, J., Silva-Garcia, R. & Ibarra, A. Cytokine and growth factor activation in vivo and in vitro after spinal cord injury. Mediators Inflamm. 2016, 9476020 (2016).

Salter, M. G. & Fern, R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438, 1167–1171 (2005).

Oka, A., Belliveau, M. J., Rosenberg, P. A. & Volpe, J. J. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention. J. Neurosci. 13, 1441–1453 (1993).

Liu, D., Liu, J., Sun, D., Alcock, N. W. & Wen, J. Spinal cord injury increases iron levels: catalytic production of hydroxyl radicals. Free Radic. Biol. Med. 34, 64–71 (2003).

Gao, M. et al. Ferroptosis is an autophagic cell death process. Cell Res. 26, 1021–1032 (2016).

Zhang, X. et al. Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52, 199–208 (2005).

Fan, B. Y. et al. Liproxstatin-1 is an effective inhibitor of oligodendrocyte ferroptosis induced by inhibition of glutathione peroxidase 4. Neural Regen. Res. 16, 561–566 (2021).

Chen, K. B. et al. Tumor necrosis factor-α antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury. Spine (Philos. Pa 1976) 36, 1350–1358 (2011).

Lee, Y. B. et al. Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury. Exp. Neurol. 166, 190–195 (2000).

Yan, P. et al. Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats. Exp. Neurol. 183, 286–297 (2003).

Yan, P. et al. Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J. Neurotrauma 18, 563–568 (2001).

Fan, B. et al. Microenvironment Imbalance of spinal cord injury. Cell Transplant. 27, 853–866 (2018).

Kanno, H., Ozawa, H., Sekiguchi, A., Yamaya, S. & Itoi, E. Induction of autophagy and autophagic cell death in damaged neural tissue after acute spinal cord injury in mice. Spine (Philos. Pa 1976) 36, E1427–E1434 (2011).

Muñoz-Galdeano, T. et al. Cell specific changes of autophagy in a mouse model of contusive spinal cord injury. Front. Cell. Neurosci. 12, 164 (2018).

Smith, C. M., Mayer, J. A. & Duncan, I. D. Autophagy promotes oligodendrocyte survival and function following dysmyelination in a long-lived myelin mutant. J. Neurosci. 33, 8088–8100 (2013).

Bankston, A. N. et al. Autophagy is essential for oligodendrocyte differentiation, survival, and proper myelination. Glia 67, 1745–1759 (2019).

Saraswat Ohri, S. et al. Blocking autophagy in oligodendrocytes limits functional recovery after spinal cord injury. J. Neurosci. 38, 5900–5912 (2018).

GrandPré, T., Nakamura, F., Vartanian, T. & Strittmatter, S. M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403, 439–444 (2000).

Huber, A. B. & Schwab, M. E. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol. Chem. 381, 407–419 (2000).

Chen, M. S. et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434–439 (2000).

Schwab, M. Functions of Nogo proteins and their receptors in the nervous system. Nat. Rev. Neurosci. 11, 799–811 (2010).

Liu, B., Fournier, A., GrandPré, T. & Strittmatter, S. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297, 1190–1193 (2002).

Domeniconi, M. et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35, 283–290 (2002).

Wang, K. C., Kim, J. A., Sivasankaran, R., Segal, R. & He, Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420, 74–78 (2002).

McTigue, D. M., Popovich, P. G., Morgan, T. E. & Stokes, B. T. Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury. Exp. Neurol. 163, 220–230 (2000).

Tripathi, R. & McTigue, D. M. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 55, 698–711 (2007).

Asher, R. A. et al. Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro. Mol. Cell. Neurosci. 29, 82–96 (2005).

Dou, C. L. & Levine, J. M. Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14, 7616–7628 (1994).

Harlow, D. E. & Macklin, W. B. Inhibitors of myelination: ECM changes, CSPGs and PTPs. Exp. Neurol. 251, 39–46 (2014).

McDonough, A., Hoang, A., Monterrubio, A., Greenhalgh, S. & Martínez-Cerdeño, V. Compression injury in the mouse spinal cord elicits a specific proliferative response and distinct cell fate acquisition along rostro-caudal and dorso-ventral axes. Neuroscience 254, 1–17 (2013).

Rabchevsky, A. G., Sullivan, P. G. & Scheff, S. W. Temporal-spatial dynamics in oligodendrocyte and glial progenitor cell numbers throughout ventrolateral white matter following contusion spinal cord injury. Glia 55, 831–843 (2007).

Hassannejad, Z. et al. Oligodendrogliogenesis and axon remyelination after traumatic spinal cord injuries in animal studies: a systematic review. Neuroscience 402, 37–50 (2019).

Assinck, P. et al. Myelinogenic plasticity of oligodendrocyte precursor cells following spinal cord contusion injury. J. Neurosci. 37, 8635–8654 (2017).

McTigue, D. M., Wei, P. & Stokes, B. T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 21, 3392–3400 (2001).

Duncan, G. J. et al. Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination. Nat. Commun. 9, 3066 (2018).

Duncan, I. D. et al. The adult oligodendrocyte can participate in remyelination. Proc. Natl. Acad. Sci. USA 115, E11807–E11816 (2018).

Bunge, M. B., Bunge, R. P. & Ris, H. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J. Biophys. Biochem. Cytol. 10, 67–94 (1961).

Guest, J. D., Hiester, E. D. & Bunge, R. P. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp. Neurol. 192, 384–393 (2005).

James, N. D. et al. Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stages. J. Neurosci. 31, 18543–18555 (2011).

Nagoshi, N. et al. Schwann cell plasticity after spinal cord injury shown by neural crest lineage tracing. Glia 59, 771–784 (2011).

Franklin, R. J. & Blakemore, W. F. Requirements for Schwann cell migration within CNS environments: a viewpoint. Int J. Dev. Neurosci. 11, 641–649 (1993).

Gage, F. H. & Temple, S. Neural stem cells: generating and regenerating the brain. Neuron 80, 588–601 (2013).

Johansson, C. B. et al. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96, 25–34 (1999).

Liu, S. & Chen, Z. Employing endogenous NSCs to promote recovery of spinal cord injury. Stem Cells Int. 2019, 1958631 (2019).

Barnabé-Heider, F. et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 7, 470–482 (2010).

Liu, Y. et al. Endogenous neural stem cells in central canal of adult rats acquired limited ability to differentiate into neurons following mild spinal cord injury. Int J. Clin. Exp. Pathol. 8, 3835–3842 (2015).

Meletis, K. et al. Spinal cord injury reveals multilineage differentiation of ependymal cells. PLoS Biol. 6, e182 (2008).

Llorens-Bobadilla, E. et al. A latent lineage potential in resident neural stem cells enables spinal cord repair. Science 370, eabb8795 (2020).

Zholudeva, L. V. et al. The neuroplastic and therapeutic potential of spinal interneurons in the injured spinal cord. Trends Neurosci. 41, 625–639 (2018).

Lu, D. C., Niu, T. & Alaynick, W. A. Molecular and cellular development of spinal cord locomotor circuitry. Front. Mol. Neurosci. 8, 25 (2015).

Laliberte, A. M., Goltash, S., Lalonde, N. R. & Bui, T. V. Propriospinal neurons: essential elements of locomotor control in the intact and possibly the injured spinal cord. Front. Cell. Neurosci. 13, 512 (2019).

Zholudeva, L. V., Karliner, J. S., Dougherty, K. J. & Lane, M. A. Anatomical recruitment of spinal V2a interneurons into phrenic motor circuitry after high cervical spinal cord injury. J. Neurotrauma 34, 3058–3065 (2017).

Rank, M. M., Flynn, J. R., Galea, M. P., Callister, R. & Callister, R. J. Electrophysiological characterization of spontaneous recovery in deep dorsal horn interneurons after incomplete spinal cord injury. Exp. Neurol. 271, 468–478 (2015).

Bareyre, F. M. et al. The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats. Nat. Neurosci. 7, 269–277 (2004).

Filli, L. et al. Bridging the gap: a reticulo-propriospinal detour bypassing an incomplete spinal cord injury. J. Neurosci. 34, 13399–13410 (2014).

May, Z. et al. Following spinal cord injury transected reticulospinal tract axons develop new collateral inputs to spinal interneurons in parallel with locomotor recovery. Neural Plast. 2017, 1932875 (2017).

Liu, Z.-H. et al. A single bolus of docosahexaenoic acid promotes neuroplastic changes in the innervation of spinal cord interneurons and motor neurons and improves functional recovery after spinal cord injury. J. Neurosci. 35, 12733–12752 (2015).

Dru, A. B. & Hoh, D. J. Activating spinal interneurons for neural repair after spinal cord injury. World Neurosurg. 84, 1185–1188 (2015).

Courtine, G. et al. Recovery of supraspinal control of stepping via indirect propriospinal relay connections after spinal cord injury. Nat. Med. 14, 69–74 (2008).

Takeoka, A., Vollenweider, I., Courtine, G. & Arber, S. Muscle spindle feedback directs locomotor recovery and circuit reorganization after spinal cord injury. Cell 159, 1626–1639 (2014).

Bui, T. V., Stifani, N., Akay, T. & Brownstone, R. M. Spinal microcircuits comprising dI3 interneurons are necessary for motor functional recovery following spinal cord transection. Elife 5, e21715 (2016).

Ganzer, P. D. et al. Restoring the sense of touch using a sensorimotor demultiplexing neural interface. Cell 181, 763–773.e12 (2020).

Hayashi, M. et al. Graded arrays of spinal and supraspinal V2a interneuron subtypes underlie forelimb and hindlimb motor control. Neuron 97, 869–884.e865 (2018).

Dougherty, K. et al. Locomotor rhythm generation linked to the output of spinal shox2 excitatory interneurons. Neuron 80, 920–933 (2013).

Caldeira, V., Dougherty, K., Borgius, L. & Kiehn, O. Spinal Hb9::Cre-derived excitatory interneurons contribute to rhythm generation in the mouse. Sci. Rep. 7, 41369 (2017).

Romer, S. H. et al. Accessory respiratory muscles enhance ventilation in ALS model mice and are activated by excitatory V2a neurons. Exp. Neurol. 287, 192–204 (2017).

Gwak, Y. S. & Hulsebosch, C. E. GABA and central neuropathic pain following spinal cord injury. Neuropharmacology 60, 799–808 (2011).

Grau, J. et al. Metaplasticity and behavior: how training and inflammation affect plastic potential within the spinal cord and recovery after injury. Front. Neural Circuits 8, 100 (2014).

Ramírez-Jarquín, U. & Tapia, R. Excitatory and inhibitory neuronal circuits in the spinal cord and their role in the control of motor neuron function and degeneration. ACS Chem. Neurosci. 9, 211–216 (2018).

Huang, H. et al. Clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019). J. Orthop. Translat. 20, 14–24 (2020).

Shultz, R. B. & Zhong, Y. Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury. Neural Regen. Res. 12, 702–713 (2017).

Lee, S. M. et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J. Neurotrauma 20, 1017–1027 (2003).

Casha, S. et al. Results of a phase Ⅱ placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain 135, 1224–1236 (2012).

Nagoshi, N., Nakashima, H. & Fehlings, M. G. Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside. Molecules 20, 7775–7789 (2015).

Grossman, R. G. et al. A prospective, multicenter, phase Ⅰ matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J. Neurotrauma 31, 239–255 (2014).

Tetreault, L. A., Zhu, M. P., Wilson, J. R., Karadimas, S. K. & Fehlings, M. G. The impact of riluzole on neurobehavioral outcomes in preclinical models of traumatic and nontraumatic spinal cord injury: results from a systematic review of the literature. Glob. Spine J. 10, 216–229 (2020).

Khorasanizadeh, M., Eskian, M., Vaccaro, A. R. & Rahimi-Movaghar, V. Granulocyte colony-stimulating factor (G-CSF) for the treatment of spinal cord injury. CNS Drugs 31, 911–937 (2017).

Inada, T. et al. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year. Spine (Philos. Pa 1976) 39, 213–219 (2014).

Azizi, M. et al. ChABC-loaded PLGA nanoparticles: a comprehensive study on biocompatibility, functional recovery, and axonal regeneration in animal model of spinal cord injury. Int J. Pharm. 577, 119037 (2020).

Pakulska, M. M., Tator, C. H. & Shoichet, M. S. Local delivery of chondroitinase ABC with or without stromal cell-derived factor 1α promotes functional repair in the injured rat spinal cord. Biomaterials 134, 13–21 (2017).

Wu, D. et al. Combining constitutively active rheb expression and chondroitinase promotes functional axonal regeneration after cervical spinal cord injury. Mol. Ther. 25, 2715–2726 (2017).

Tator, C. H. et al. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J. Neurosurg. Spine 17, 157–229 (2012).

Thibault-Halman, G. et al. Predicting recruitment feasibility for acute spinal cord injury clinical trials in Canada using national registry data. J. Neurotrauma 34, 599–606 (2017).

Ulndreaj, A., Badner, A. & Fehlings, M. G. Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury. F1000Res 6, 1907 (2017).

Fehlings, M. G. et al. A phase Ⅰ/Ⅱa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J. Neurotrauma 28, 787–796 (2011).

Freund, P. et al. Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey. J. Comp. Neurol. 502, 644–659 (2007).

Kucher, K. et al. First-in-man intrathecal application of neurite growth-promoting anti-nogo-A Antibodies in Acute Spinal Cord Injury. Neurorehabil Neural Repair 32, 578–589 (2018).

Wu, J. C., Huang, W. C., Tsai, Y. A., Chen, Y. C. & Cheng, H. Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary Phase Ⅰ clinical study. J. Neurosurg. Spine 8, 208–214 (2008).

Zhou, Y., Wang, Z., Li, J., Li, X. & Xiao, J. Fibroblast growth factors in the management of spinal cord injury. J. Cell. Mol. Med. 22, 25–37 (2018).

Hall, E. D. & Braughler, J. M. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg. Neurol. 18, 320–327 (1982).

Hall, E. D. & Braughler, J. M. Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and Na+ + K+)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat. J. Neurosurg 57, 247–253 (1982).

Bracken, M. B. et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 251, 45–52 (1984).

Bracken, M. B. et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322, 1405–1411 (1990).

Coleman, W. P. et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (Ⅱ and Ⅲ) of methylprednisolone in acute spinal cord injury. J. Spinal Disord. 13, 185–199 (2000).

Hurlbert, R. J. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J. Neurosurg. 93, 1–7 (2000).

Bracken, M. B. et al. Administration of methylprednisolone for 24 or 48 h or tirilazad mesylate for 48 h in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277, 1597–1604 (1997).

Bracken, M. B. Steroids for acute spinal cord injury. Cochrane Database Syst. Rev. 1, Cd001046 (2012).

Fehlings, M. G. et al. A clinical practice guideline for the management of patients with acute spinal cord injury: recommendations on the use of methylprednisolone sodium succinate. Glob. Spine J. 7, 203s–211s (2017).

Evaniew, N. et al. Methylprednisolone for the treatment of patients with acute spinal cord injuries: a propensity score-matched cohort study from a Canadian Multi-Center Spinal Cord Injury Registry. J. Neurotrauma 32, 1674–1683 (2015).

Liu, L. J. W., Rosner, J. & Cragg, J. J. Journal Club: high-dose methylprednisolone for acute traumatic spinal cord injury: a meta-analysis. Neurology 95, 272–274 (2020).

Roquilly, A. et al. French recommendations for the management of patients with spinal cord injury or at risk of spinal cord injury. Anaesth. Crit. Care Pain. Med. 39, 279–289 (2020).

Walters, B. C. et al. Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery 60, 82–91 (2013).

Wells, J. E., Hurlbert, R. J., Fehlings, M. G. & Yong, V. W. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126, 1628–1637 (2003).

Festoff, B. W. et al. Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J. Neurochem. 97, 1314–1326 (2006).

Teng, Y. D. et al. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc. Natl. Acad. Sci. USA 101, 3071–3076 (2004).

Pinzon, A. et al. A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res. 1243, 146–151 (2008).

Lee, J. H. et al. Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury. Exp. Neurol. 225, 219–230 (2010).

Stutzmann, J. M., Pratt, J., Boraud, T. & Gross, C. The effect of riluzole on post-traumatic spinal cord injury in the rat. Neuroreport 7, 387–392 (1996).

Kitzman, P. H. Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat. Neurosci. Lett. 455, 150–153 (2009).

Yoon, S. H. et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase Ⅰ/Ⅱ clinical trial. Stem Cells 25, 2066–2073 (2007).

Takahashi, H. et al. Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase Ⅰ/Ⅱa clinical trial. Eur. Spine J. 21, 2580–2587 (2012).

Di Gregorio, F., Ferrari, G., Marini, P., Siliprandi, R. & Gorio, A. The influence of gangliosides on neurite growth and regeneration. Neuropediatrics 15, 93–96 (1984).

Bose, B., Osterholm, J. L. & Kalia, M. Ganglioside-induced regeneration and reestablishment of axonal continuity in spinal cord-transected rats. Neurosci. Lett. 63, 165–169 (1986).

Geisler, F. H., Dorsey, F. C. & Coleman, W. P. Recovery of motor function after spinal-cord injury−a randomized, placebo-controlled trial with GM-1 ganglioside. N. Engl. J. Med. 324, 1829–1838 (1991).

Geisler, F. H., Coleman, W. P., Grieco, G. & Poonian, D. The Sygen multicenter acute spinal cord injury study. Spine (Philos. Pa 1976) 26, S87–S98 (2001).

Jevans, B. et al. Combined treatment with enteric neural stem cells and chondroitinase ABC reduces spinal cord lesion pathology. Stem Cell Res. Ther. 12, 10 (2021).

Fouad, K. et al. Combining Schwann cell bridges and olfactory-ensheathing glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J. Neurosci. 25, 1169–1178 (2005).

Dergham, P. et al. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22, 6570–6577 (2002).

Stern, S. et al. RhoA drives actin compaction to restrict axon regeneration and astrocyte reactivity after CNS injury. Neuron 109, 3436–3455.e3439 (2021).

Schwab, M. E. & Caroni, P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J. Neurosci. 8, 2381–2393 (1988).

Schnell, L. & Schwab, M. E. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343, 269–272 (1990).

Fouad, K., Klusman, I. & Schwab, M. E. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur. J. Neurosci. 20, 2479–2482 (2004).

Logan, A. & Berry, M. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol. Sci. 14, 337–342 (1993).

Ribeiro-Resende, V. T., Carrier-Ruiz, A., Lemes, R. M., Reis, R. A. & Mendez-Otero, R. Bone marrow-derived fibroblast growth factor-2 induces glial cell proliferation in the regenerating peripheral nervous system. Mol. Neurodegener. 7, 34 (2012).

Hohn, A., Leibrock, J., Bailey, K. & Barde, Y. A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344, 339–341 (1990).

Tuszynski, M. H. et al. NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection. Exp. Neurol. 181, 47–56 (2003).

Helgren, M. E. et al. Neurotrophin-3 administration attenuates deficits of pyridoxine-induced large-fiber sensory neuropathy. J. Neurosci. 17, 372–382 (1997).

Gao, W. Q. et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann. Neurol. 38, 30–37 (1995).

Levi-Montalcini, R. & Hamburger, V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J. Exp. Zool. 116, 321–361 (1951).

Grill, R. J., Blesch, A. & Tuszynski, M. H. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp. Neurol. 148, 444–452 (1997).

Tuszynski, M. H. et al. Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury. Exp. Neurol. 137, 157–173 (1996).

Saadeh, Y. S. et al. The impact of blood pressure management after spinal cord injury: a systematic review of the literature. Neurosurg. Focus 43, E20 (2017).

Wilson, J. R., Forgione, N. & Fehlings, M. G. Emerging therapies for acute traumatic spinal cord injury. CMAJ 185, 485–492 (2013).

Readdy, W. J. & Dhall, S. S. Vasopressor administration in spinal cord injury: should we apply a universal standard to all injury patterns? Neural Regen. Res. 11, 420–421 (2016).

Hawryluk, G. et al. Mean arterial blood pressure correlates with neurological recovery after human spinal cord injury: analysis of high frequency physiologic data. J. Neurotrauma 32, 1958–1967 (2015).

Gunnarsson, T. & Fehlings, M. G. Acute neurosurgical management of traumatic brain injury and spinal cord injury. Curr. Opin. Neurol. 16, 717–723 (2003).

Karsy, M. & Hawryluk, G. Pharmacologic management of acute spinal cord injury. Neurosurg. Clin. N. Am. 28, 49–62 (2017).

Kanekiyo, K. et al. Effects of multiple injection of bone marrow mononuclear cells on spinal cord injury of rats. J. Neurotrauma 34, 3003–3011 (2017).

Ritfeld, G. J. et al. The role of brain-derived neurotrophic factor in bone marrow stromal cell-mediated spinal cord repair. Cell Transplant. 24, 2209–2220 (2015).

Jin, M. C., Medress, Z. A., Azad, T. D., Doulames, V. M. & Veeravagu, A. Stem cell therapies for acute spinal cord injury in humans: a review. Neurosurg. Focus 46, E10 (2019).

Vismara, I., Papa, S., Rossi, F., Forloni, G. & Veglianese, P. Current options for cell therapy in spinal cord injury. Trends Mol. Med. 23, 831–849 (2017).

Assinck, P., Duncan, G. J., Hilton, B. J., Plemel, J. R. & Tetzlaff, W. Cell transplantation therapy for spinal cord injury. Nat. Neurosci. 20, 637–647 (2017).

Gong, Z. et al. Stem cell transplantation: a promising therapy for spinal cord injury. Curr. Stem Cell Res. Ther. 15, 321–331 (2020).

Cofano, F. et al. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int. J. Mol. Sci. 20, 2698 (2019).

Oh, S. K. et al. A phase Ⅲ clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery 78, 436–447 (2016).

Anderson, K. D. et al. Safety of autologous human schwann cell transplantation in subacute thoracic spinal cord injury. J. Neurotrauma 34, 2950–2963 (2017).

Curtis, E. et al. A first-in-human, phase Ⅰ study of neural stem cell transplantation for chronic spinal cord injury. Cell Stem Cell 22, 941–950 (2018).

Levi, A. D. et al. Clinical Outcomes from a Multi-Center Study of Human Neural Stem Cell Transplantation in Chronic Cervical Spinal Cord Injury. J. Neurotrauma 36, 891–902 (2019).

Zhu, H. et al. Phase Ⅰ-Ⅱ clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury. Cell Transplant. 25, 1925–1943 (2016).

Tabakow, P. et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 22, 1591–1612 (2013).

Chang, D. J. et al. Therapeutic effect of BDNF-overexpressing human neural stem cells (F3.BDNF) in a contusion model of spinal cord injury in rats. Int. J. Mol. Sci. 22, 6970 (2021).

Ying, Y. et al. Hypoxia response element-directed expression of aFGF in neural stem cells promotes the recovery of spinal cord injury and attenuates SCI-Induced Apoptosis. Front. Cell Dev. Biol. 9, 693694 (2021).

Fan, W. L. et al. Transplantation of hypoxic preconditioned neural stem cells benefits functional recovery via enhancing neurotrophic secretion after spinal cord injury in rats. J. Cell Biochem. 119, 4339–4351 (2018).

Zou, Y. et al. Aligned collagen scaffold combination with human spinal cord-derived neural stem cells to improve spinal cord injury repair. Biomater. Sci. 8, 5145–5156 (2020).

Chen, D., Hu, S., Liu, J. & Li, S. E-cadherin regulates biological behaviors of neural stem cells and promotes motor function recovery following spinal cord injury. Exp. Ther. Med. 17, 2061–2070 (2019).

Cusimano, M. et al. Selective killing of spinal cord neural stem cells impairs locomotor recovery in a mouse model of spinal cord injury. J. Neuroinflammation 15, 58 (2018).

Ogawa, Y. et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. 69, 925–933 (2002).

Mothe, A. J. & Tator, C. H. Review of transplantation of neural stem/progenitor cells for spinal cord injury. Int. J. Dev. Neurosci. 31, 701–713 (2013).

Zhu, Y., Uezono, N., Yasui, T. & Nakashima, K. Neural stem cell therapy aiming at better functional recovery after spinal cord injury. Dev. Dyn. 247, 75–84 (2018).

Curtis, E. et al. A first-in-human, phase Ⅰ study of neural stem cell transplantation for chronic spinal cord injury. Cell Stem Cell 22, 941–950.e946 (2018).

de Miguel Beriain, I. What is a human embryo? A new piece in the bioethics puzzle. Croat. Med J. 55, 669–671 (2014).

Kobayashi, Y. et al. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity. PLoS One 7, e52787 (2012).

Ring, K. L. et al. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11, 100–109 (2012).

Dasari, V. R., Veeravalli, K. K. & Dinh, D. H. Mesenchymal stem cells in the treatment of spinal cord injuries: a review. World J. Stem Cells 6, 120–133 (2014).

Fuhrmann, T. et al. Axon growth-promoting properties of human bone marrow mesenchymal stromal cells. Neurosci. Lett. 474, 37–41 (2010).

Crigler, L., Robey, R. C., Asawachaicharn, A., Gaupp, D. & Phinney, D. G. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp. Neurol. 198, 54–64 (2006).

Hawryluk, G. W. et al. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 21, 2222–2238 (2012).

Neirinckx, V. et al. Concise review: Spinal cord injuries: how could adult mesenchymal and neural crest stem cells take up the challenge? Stem Cells 32, 829–843 (2014).

Nakajima, H. et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J. Neurotrauma 29, 1614–1625 (2012).

Gao, S. et al. Anti-inflammatory and anti-apoptotic effect of combined treatment with methylprednisolone and amniotic membrane mesenchymal stem cells after spinal cord injury in rats. Neurochem Res. 39, 1544–1552 (2014).

Dasari, V. et al. Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury. J. Neurotrauma 26, 2057–2069 (2009).

Bottai, D. et al. Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury. Exp. Neurol. 254, 121–133 (2014).

Oh, S. K. et al. A phase Ⅲ clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery 78, 436–447 (2016).

Vaquero, J. et al. An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase Ⅰ/Ⅱ clinical trial. Cytotherapy 18, 1025–1036 (2016).

Dai, G. et al. Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury. Brain Res. 1533, 73–79 (2013).

El-Kheir, W. A. et al. Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients. Cell Transplant. 23, 729–745 (2014).

Duncan, I., Aguayo, A., Bunge, R. & Wood, P. Transplantation of rat Schwann cells grown in tissue culture into the mouse spinal cord. J. Neurol. Sci. 49, 241–252 (1981).

Lankford, K. L., Imaizumi, T., Honmou, O. & Kocsis, J. D. A quantitative morphometric analysis of rat spinal cord remyelination following transplantation of allogenic Schwann cells. J. Comp. Neurol. 443, 259–274 (2002).

Zhang, S., Huang, F., Gates, M. & Holmberg, E. Role of endogenous Schwann cells in tissue repair after spinal cord injury. Neural Regen. Res. 8, 177–185 (2013).

Bunge, M. B. & Wood, P. M. Realizing the maximum potential of Schwann cells to promote recovery from spinal cord injury. Handb. Clin. Neurol. 109, 523–540 (2012).

Myers, S. A., Bankston, A. N., Burke, D. A., Ohri, S. S. & Whittemore, S. R. Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? Exp. Neurol. 283, 560–572 (2016).

Namjoo, Z. et al. Combined effects of rat Schwann cells and 17beta-estradiol in a spinal cord injury model. Metab. Brain Dis. 33, 1229–1242 (2018).

Zhou, X. H. et al. Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up. Cell Transplant. 21, S39–S47 (2012).

Saberi, H. et al. Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases. J. Neurosurg. Spine 15, 515–525 (2011).

Bunge, M. B. Efficacy of Schwann cell transplantation for spinal cord repair is improved with combinatorial strategies. J. Physiol. 594, 3533–3538 (2016).

Okano, H. et al. Steps toward safe cell therapy using induced pluripotent stem cells. Circ. Res. 112, 523–533 (2013).

Bellak, T. et al. Grafted human induced pluripotent stem cells improve the outcome of spinal cord injury: modulation of the lesion microenvironment. Sci. Rep. 10, 22414 (2020).

Khazaei, M., Ahuja, C. S. & Fehlings, M. G. Induced pluripotent stem cells for traumatic spinal cord injury. Front. Cell Dev. Biol. 4, 152 (2016).

Nagoshi, N., Tsuji, O., Nakamura, M. & Okano, H. Cell therapy for spinal cord injury using induced pluripotent stem cells. Regen. Ther. 11, 75–80 (2019).

Kawabata, S. et al. Grafted human iPS cell-derived oligodendrocyte precursor cells contribute to robust remyelination of demyelinated axons after spinal cord injury. Stem Cell Rep. 6, 1–8 (2016).

Gilmour, A. D., Reshamwala, R., Wright, A. A., Ekberg, J. A. K. & St John, J. A. Optimizing olfactory ensheathing cell transplantation for spinal cord injury repair. J. Neurotrauma 37, 817–829 (2020).

Li, Y., Field, P. & Raisman, G. Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277, 2000–2002 (1997).

Kato, T., Honmou, O., Uede, T., Hashi, K. & Kocsis, J. Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 30, 209–218 (2000).

Pastrana, E. et al. BDNF production by olfactory ensheathing cells contributes to axonal regeneration of cultured adult CNS neurons. Neurochem. Int. 50, 491–498 (2007).

Lu, J. & Ashwell, K. Olfactory ensheathing cells: their potential use for repairing the injured spinal cord. Spine 27, 887–892 (2002).

López-Vales, R., García-Alías, G., Forés, J., Navarro, X. & Verdú, E. Increased expression of cyclo-oxygenase 2 and vascular endothelial growth factor in lesioned spinal cord by transplanted olfactory ensheathing cells. J. Neurotrauma 21, 1031–1043 (2004).

Chen, L. et al. A prospective randomized double-blind clinical trial using a combination of olfactory ensheathing cells and Schwann cells for the treatment of chronic complete spinal cord injuries. Cell Transplant. 23, S35–S44 (2014).

Lima, C. et al. Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair 24, 10–22 (2010).

Dobkin, B. H., Curt, A. & Guest, J. Cellular transplants in China: observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair 20, 5–13 (2006).

Mackay-Sim, A. et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 131, 2376–2386 (2008).

Guest, J. & Dietrich, W. Commentary regarding the recent publication by Tabakow et al., “functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging”. J. Neurotrauma 32, 1176–1178 (2015).

Erceg, S. et al. Differentiation of human embryonic stem cells to regional specific neural precursors in chemically defined medium conditions. PLoS One 3, e2122 (2008).

McDonald, J. et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat. Med. 5, 1410–1412 (1999).

Shroff, G. Human embryonic stem cell therapy in chronic spinal cord injury: a retrospective study. Clin. Transl. Sci. 9, 168–175 (2016).

Shroff, G. & Gupta, R. Human embryonic stem cells in the treatment of patients with spinal cord injury. Ann. Neurosci. 22, 208–216 (2015).

Frantz, S. Embryonic stem cell pioneer Geron exits field, cuts losses. Nat. Biotechnol. 30, 12–13 (2012).

Li, J. Y., Christophersen, N. S., Hall, V., Soulet, D. & Brundin, P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci. 31, 146–153 (2008).

Rapalino, O. et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat. Med. 4, 814–821 (1998).

Shin, T., Ahn, M., Moon, C., Kim, S. & Sim, K. B. Alternatively activated macrophages in spinal cord injury and remission: another mechanism for repair? Mol. Neurobiol. 47, 1011–1019 (2013).

Li, Z. et al. viaM2 macrophages promote PDGFRβ Pericytes Migration After Spinal Cord Injury in Mice PDGFB/PDGFRβ pathway. Front. Pharmacol. 12, 670813 (2021).

Knoller, N. et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase Ⅰ study results. J. Neurosurg. Spine 3, 173–181 (2005).

Nazari, B. et al. miR-219 overexpressing oligodendrocyte progenitor cells for treating compression spinal cord injury. Metab. Brain Dis. 36, 1069–1077 (2021).

Duncan, G. J. et al. The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury. Glia 68, 227–245 (2020).

Keirstead, H. S. et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694–4705 (2005).

Kim, J. B. et al. Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model. EMBO J. 34, 2971–2983 (2015).

Wang, Y., Piao, J. H., Larsen, E. C., Kondo, Y. & Duncan, I. D. Migration and remyelination by oligodendrocyte progenitor cells transplanted adjacent to focal areas of spinal cord inflammation. J. Neurosci. Res. 89, 1737–1746 (2011).

Manley, N., Priest, C., Denham, J., Wirth, E. & Lebkowski, J. Human embryonic stem cell-derived oligodendrocyte progenitor cells: preclinical efficacy and safety in cervical spinal cord injury. Stem Cells Transl. Med. 6, 1917–1929 (2017).

Zavvarian, M.-M., Toossi, A., Khazaei, M., Hong, J. & Fehlings, M. Novel innovations in cell and gene therapies for spinal cord injury. F1000Res 9, F1000 Faculty Rev-279 (2020).

Leng, Z.-K. et al. Cultivation, screening, identification and transplantation of Muse cell from human umbilical cord-derived for spinal cord injury in rats. Zhongguo Gu Shang 32, 327–334 (2019).

Fandel, T. M. et al. Transplanted human stem cell-derived interneuron precursors mitigate mouse bladder dysfunction and central neuropathic pain after spinal cord injury. Cell Stem Cell 19, 544–557 (2016).

Blesch, A. Human ESC-derived interneurons improve major consequences of spinal cord injury. Cell Stem Cell 19, 423–424 (2016).

Huang, J. H. et al. Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in rats. J. Neurotrauma 34, 3388–3396 (2017).

Zhao, C. et al. Exosomes derived from bone marrow mesenchymal stem cells inhibit complement activation in rats with spinal cord injury. Drug Des. Devel. Ther. 13, 3693–3704 (2019).

Zhang, C. et al. Exosomes derived from human placenta-derived mesenchymal stem cells improve neurologic function by promoting angiogenesis after spinal cord injury. Neurosci. Lett. 739, 135399 (2020).

Frohlich, D. et al. Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369, 20130510 (2014).

Jiang, D. et al. Neuron-derived exosomes-transmitted miR-124-3p protect traumatically injured spinal cord by suppressing the activation of neurotoxic microglia and astrocytes. J. Nanobiotechnol. 18, 105 (2020).

Shao, M. et al. Exosomes from long noncoding RNA-Gm37494-ADSCs repair spinal cord injury via shifting microglial M1/M2 polarization. Inflammation 43, 1536–1547 (2020).

Yuan, B., Pan, S., Dong, Y. Q., Zhang, W. W. & He, X. D. Effect of exosomes derived from mir-126-modified mesenchymal stem cells on the repair process of spinal cord injury in rats. Eur. Rev. Med. Pharmacol. Sci. 24, 4058 (2020).

Guo, S. et al. Intranasal delivery of mesenchymal stem cell derived exosomes loaded with phosphatase and tensin homolog siRNA repairs complete spinal cord injury. ACS Nano 13, 10015–10028 (2019).

Li, L. et al. Transplantation of human mesenchymal stem-cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury. Nano Lett. 20, 4298–4305 (2020).

Wei, Z. et al. Proteomics analysis of Schwann cell-derived exosomes: a novel therapeutic strategy for central nervous system injury. Mol. Cell Biochem. 457, 51–59 (2019).

Rao, J. S. et al. NT3-chitosan enables de novo regeneration and functional recovery in monkeys after spinal cord injury. Proc. Natl. Acad. Sci. USA 115, E5595–E5604 (2018).

Yang, Z. et al. NT3-chitosan elicits robust endogenous neurogenesis to enable functional recovery after spinal cord injury. Proc. Natl. Acad. Sci. USA 112, 13354–13359 (2015).

Zhou, X. et al. Polycaprolactone electrospun fiber scaffold loaded with iPSCs-NSCs and ASCs as a novel tissue engineering scaffold for the treatment of spinal cord injury. Int J. Nanomed. 13, 6265–6277 (2018).

Saracino, G., Cigognini, D., Silva, D., Caprini, A. & Gelain, F. Nanomaterials design and tests for neural tissue engineering. Chem. Soc. Rev. 42, 225–262 (2013).

Xu, Y. et al. Understanding the role of tissue-specific decellularized spinal cord matrix hydrogel for neural stem/progenitor cell microenvironment reconstruction and spinal cord injury. Biomaterials 268, 120596 (2021).

Lu, P. et al. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150, 1264–1273 (2012).

Liu, X. et al. 3D bioprinted neural tissue constructs for spinal cord injury repair. Biomaterials 272, 120771 (2021).

Zhou, X. et al. Three-dimensional-bioprinted dopamine-based matrix for promoting neural regeneration. ACS Appl. Mater. Interfaces 10, 8993–9001 (2018).

Lee, S. J. et al. 3D printing nano conductive multi-walled carbon nanotube scaffolds for nerve regeneration. J. Neural Eng. 15, 016018 (2018).

Koffler, J. et al. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat. Med. 25, 263–269 (2019).

Joung, D. et al. 3D printed stem-cell derived neural progenitors generate spinal cord scaffolds. Adv. Funct. Mater. 28, 1801850 (2018).

Liu, W. et al. A functional scaffold to promote the migration and neuronal differentiation of neural stem/progenitor cells for spinal cord injury repair. Biomaterials 243, 119941 (2020).

Li, X. et al. A collagen microchannel scaffold carrying paclitaxel-liposomes induces neuronal differentiation of neural stem cells through Wnt/β-catenin signaling for spinal cord injury repair. Biomaterials 183, 114–127 (2018).

Xiao, Z. et al. Significant improvement of acute complete spinal cord injury patients diagnosed by a combined criteria implanted with NeuroRegen scaffolds and mesenchymal stem cells. Cell Transplant. 27, 907–915 (2018).

Duan, H. et al. Transcriptome analyses reveal molecular mechanisms underlying functional recovery after spinal cord injury. Proc. Natl. Acad. Sci. USA 112, 13360–13365 (2015).

Theodore, N. et al. First human implantation of a bioresorbable polymer scaffold for acute traumatic spinal cord injury: a clinical pilot study for safety and feasibility. Neurosurgery 79, E305–E312 (2016).

Kim, K. D. et al. A study of probable benefit of a bioresorbable polymer scaffold for safety and neurological recovery in patients with complete thoracic spinal cord injury: 6-month results from the INSPIRE study. J. Neurosurg. Spine, 1–10. (2021).

Caiazzo, M. et al. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476, 224–227 (2011).

Heinrich, C. et al. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol. 8, e1000373 (2010).

Su, Z., Niu, W., Liu, M. L., Zou, Y. & Zhang, C. L. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat. Commun. 5, 3338 (2014).

Heinrich, C. et al. Sox2-mediated conversion of NG2 glia into induced neurons in the injured adult cerebral cortex. Stem Cell Rep. 3, 1000–1014 (2014).

Son, E. et al. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9, 205–218 (2011).

Zarei-Kheirabadi, M., Hesaraki, M., Kiani, S. & Baharvand, H. In vivo conversion of rat astrocytes into neuronal cells through neural stem cells in injured spinal cord with a single zinc-finger transcription factor. Stem Cell Res. Ther. 10, 380 (2019).

Matsuda, T. et al. Pioneer factor NeuroD1 rearranges transcriptional and epigenetic profiles to execute microglia-neuron conversion. Neuron 101, 472–485.e477 (2019).

Karow, M. et al. Direct pericyte-to-neuron reprogramming via unfolding of a neural stem cell-like program. Nat. Neurosci. 21, 932–940 (2018).

Hu, W. et al. Direct conversion of normal and Alzheimer’s DIsease Human Fibroblasts Into Neuronal Cells by Small Molecules. Cell Stem Cell 17, 204–212 (2015).

Chavez, A. et al. Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12, 326–328 (2015).

Wang, L. L. et al. Revisiting astrocyte to neuron conversion with lineage tracing in vivo. Cell 184, 5465–5481.e5416 (2021).

Patel, N. P. & Huang, J. H. Hyperbaric oxygen therapy of spinal cord injury. Med. Gas. Res. 7, 133–143 (2017).

Zhou, Y. et al. Hyperbaric oxygen improves functional recovery of the injured spinal cord by inhibiting inflammation and glial scar formation. Am. J. Phys. Med. Rehabil. 98, 914–920 (2019).

Huang, G. et al. Signaling pathways involved in HSP32 induction by hyperbaric oxygen in rat spinal neurons. Redox Biol. 10, 108–118 (2016).

Tan, J. W., Zhang, F., Liu, H. J. & Li, Z. Hyperbaric oxygen ameliorated the lesion scope and nerve function in acute spinal cord injury patients: a retrospective study. Clin. Biochem. 53, 1–7 (2018).

Sun, L. et al. Effect of hyperbaric oxygen therapy on HMGB1/NF-κB expression and prognosis of acute spinal cord injury: a randomized clinical trial. Neurosci. Lett. 692, 47–52 (2019).

Hwang, D. H., Park, H. H., Shin, H. Y., Cui, Y. & Kim, B. G. Insulin-like growth factor-1 receptor dictates beneficial effects of treadmill training by regulating survival and migration of neural stem cell grafts in the injured spinal cord. Exp. Neurobiol. 27, 489–507 (2018).

Hwang, D. H. et al. Survival of neural stem cell grafts in the lesioned spinal cord is enhanced by a combination of treadmill locomotor training via insulin-like growth factor-1 signaling. J. Neurosci. 34, 12788–12800 (2014).

Behrman, A. L., Ardolino, E. M. & Harkema, S. J. Activity-based therapy: from basic science to clinical application for recovery after spinal cord injury. J. Neurol. Phys. Ther. 41, S39–S45 (2017).

Shaffer, R. F., Picard, G. & Taylor, J. A. Relationship of spinal cord injury level and duration to peak aerobic capacity with arms-only and hybrid functional electrical stimulation rowing. Am. J. Phys. Med. Rehabil. 97, 488–491 (2018).

Zhang, C. et al. Early applied electric field stimulation attenuates secondary apoptotic responses and exerts neuroprotective effects in acute spinal cord injury of rats. Neuroscience 291, 260–271 (2015).

Li, G. et al. Epidural spinal cord stimulation promotes motor functional recovery by enhancing oligodendrocyte survival and differentiation and by protecting myelin after spinal cord injury in rats. Neurosci. Bull. 36, 372–384 (2020).

Hutson, T. H. & Di Giovanni, S. The translational landscape in spinal cord injury: focus on neuroplasticity and regeneration. Nat. Rev. Neurol. 15, 732–745 (2019).

Mishra, A. M., Pal, A., Gupta, D. & Carmel, J. B. Paired motor cortex and cervical epidural electrical stimulation timed to converge in the spinal cord promotes lasting increases in motor responses. J. Physiol. 595, 6953–6968 (2017).

Formento, E. et al. Electrical spinal cord stimulation must preserve proprioception to enable locomotion in humans with spinal cord injury. Nat. Neurosci. 21, 1728–1741 (2018).

Wenger, N. et al. Spatiotemporal neuromodulation therapies engaging muscle synergies improve motor control after spinal cord injury. Nat. Med. 22, 138–145 (2016).

Capogrosso, M. et al. A brain-spine interface alleviating gait deficits after spinal cord injury in primates. Nature 539, 284–288 (2016).

Wagner, F. B. et al. Targeted neurotechnology restores walking in humans with spinal cord injury. Nature 563, 65–71 (2018).

Greiner, N. et al. Recruitment of upper-limb motoneurons with epidural electrical stimulation of the cervical spinal cord. Nat. Commun. 12, 435 (2021).